1. Summary Information

 

 

Country

India

Company Name

SHREYA LIFE SCIENCES PRIVATE LIMIYED

Principal Name 1

Mr. Sujitkumar Jagannath Singh

Status

Satisfactory

Principal Name 2

Mr. Sheel Kumar Singh

 

 

Registration #

11-061136

Street Address

Shreya House, 6th Floor, 301/A Pereira Hill Road, Andheri (East), Mumbai – 400099, Maharashtra, India

Established Date

10.04.1991

SIC Code

--

Telephone#

91-22-66938222/ 66959844 / 42220236

Business Style 1

Manufacturer

Fax #

91-22-66939222

Business Style 2

Trader

Homepage

www.shreya.co.in

Product Name 1

Ethambutol (Combutol)

 

# of employees

Approximately 600

Product Name 2

Pharmaceuticals

Paid up capital

Rs. 62,954,600/-

Product Name 3

Bulk Drugs

Shareholders

Foreign holdings (17.00%)

Directors or relatives of directors (83.00%)

Banking

Bank of India

Public Limited Corp.

NO

Business Period

20 Years

IPO

NO

International Ins.

-

Public Enterprise

NO

Rating

Ba (50)

Related Company

Relation

Country

Company Name

CEO

Subsidiary Company

India

Serena Pharma Private Limited

--

Note

-

2. Summary Financial Statement

Balance Sheet as of

31.03.2009

(Unit: Indian Rs.)

Assets

Liabilities

Current Assets

3,342,769,000

Current Liabilities

1,269,496,000

Inventories

307,978,000

Long-term Liabilities

1,800,930,000

Fixed Assets

1,247,598,000

Other Liabilities

63,454,000

Deferred Assets

58,792,000

Total Liabilities

3,133,880,000

Invest& other Assets

61,799,000

Retained Earnings

1,622,101,000

 

 

Net Worth

1,885,056,000

Total Assets

5,018,936,000

Total Liab. & Equity

5,018,936,000

 Total Assets

(Previous Year)

4,581,124,000

 

 

P/L Statement as of

31.03.2009

(Unit: Indian Rs.)

Sales

--

Net Profit

255,701,000

Sales(Previous yr)

4,392,459,000

Net Profit(Prev.yr)

325,149,000

           


MIRA INFORM REPORT

 

 

Report Date :

13.01.2011

 

IDENTIFICATION DETAILS

 

Name :

SHREYA LIFE SCIENCES PRIVATE LIMIYED

 

 

Formerly Known As :

AMIKA TRADING PRIVATE LIMITED

 

 

Registered Office :

Shreya House, 6th Floor, 301/A Pereira Hill Road, Andheri (East), Mumbai – 400099, Maharashtra

 

 

Country :

India

 

 

Financials (as on) :

31.03.2009

 

 

Date of Incorporation :

10.04.1991

 

 

Com. Reg. No.:

11-061136

 

 

CIN No.:

[Company Identification No.]

U51900MH1991PTC061136

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Manufacturer and Trader of Pharmaceuticals and Bulk Drugs.

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba (50)

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

USD 7500000

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company having satisfactory track. Trade relations are reported as fair. Business is active. Payments are reported to be regular and as per commitments.

 

The company can be considered normal for business dealings at usual trade terms and conditions.

 

The latest Profit and Loss of the company is not available.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – April 1, 2010

 

Country Name

Previous Rating

(31.12.2009)

Current Rating

(01.04.2010)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

INFORMATION PARTED BY [General Details]

 

Name :

Mr. Sujit Kumar Singh

Designation :

Director

 

 

LOCATIONS

 

Registered/ Head Office :

Shreya House, 6th Floor, 301/A Pereira Hill Road, Andheri (East), Mumbai – 400099, Maharashtra, India

Tel. No.:

91-22-66938222/ 66959844 / 42220236

Fax No.:

91-22-66939222

E-Mail :

datta@shreya.co.in

shreya@shreya.co.in

corporate@shreya.co.in

sujit@shreya.co.in

Website :

www.shreya.co.in

Location :

3000 sq. ft. [Owned]

 

 

Aurangabad Plant Office :

B-9/2, MIDC, Waluj – 431136, Aurangabad, India

Tel. No.:

91-240-6636700

Fax No.:

91-240-2554581

E-Mail :

shreya@shreya.co.in

 

 

Roorkee Plant Office :

Plot No.13/14/15, Village: Raipur and Sisona, Post Office: Bhagwanpur, District Haridwar (Uttarakhand) – 247667, Roorkee, India

Tel. No.:

91-1332-287287 / 287211

Fax No.:

91-1332-232755 / 235244

E-Mail :

shreya@shreya.co.in

 

 

DIRECTORS

 

AS ON 15.09.2010

 

Name :

Mr. Sujitkumar Jagannath Singh

Designation :

Chairman and Managing Director

Address :

1302, Wallace Apartment – I Sieater Road, Grant Road – West, Mumbai – 400007, Maharashtra, India

Date of Birth/Age :

15.03.1971

Date of Appointment :

30.09.1999

 

 

Name :

Mr. Sheel Kumar Singh

Designation :

Director

Address :

37 Surag Apartments, Nutan Laxmi Co-op Society, 10th Road, Vile Parle (West), Mumbai – 400049, Maharashtra, India

Date of Birth/Age :

10.02.1973

Date of Appointment :

14.09.2006

Email :

sheel.kumar@shreyacom.com

Other Directorship

Companies:

Shreya Creations Private Limited

Director

U92100MH2000PTC124644

 

Shreya Com Private Limited

Director

U72900MH2000PTC126235

 

 

Name :

Mr. Vivekanand Sharadanand Jha

Designation :

Director

Address :

15, Hardev Sai Society, Caves Road, Jogeshwari East, Mumbai – 400060, Maharashtra, India

Date of Birth/Age :

14.02.1970

Date of Appointment :

30.01.2002

 

 

Name :

Mr. Himanshu Baldev Singh

Designation :

Director

Address :

Sneha 82, Nutan Lxmi Soc. N.S. Road No – 8, Juhu Scheme, G.V.P.D. Vile Parle [West], Mumbai – 400049, Maharashtra, India

Date of Birth/Age :

01.01.1977

Date of Appointment :

20.03.2009

 

 

Name :

Mr. Radha Krishna Nagpal

Designation :

Director

Address :

7/102, Sagar Kiran Kannamawar Nagar, No.1 Vikjroli – East, Mumbai – 400083, Maharashtra, India

Date of Birth/Age :

01.05.1954

Date of Appointment :

06.04.2004

Date of Ceasing :

20.03.2009

 

 

KEY EXECUTIVES

 

Name :

Mr. Amal Tripathi

Designation :

Company Secretary

Address :

C-402, 4th Floor Prathvi Park, Sector-30, Sanpada, Navi Mumbai-400705, Maharashtra, India

Date of Birth/Age :

29.09.1973

Date of Appointment :

01.07.2010

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

AS ON 15.09.2010

 

Names of Shareholders

 

No. of Shares

 

 

 

Sujit Kumar Singh

 

1971860

R S Investments Limited, British Vergin Island

 

1070320

Jagannath Prasad Singh

 

1364740

Vishwananth Prasad

 

944300

Baidhnath Singh

 

944240

 

 

 

Total

 

6295460

 

Equity Share Breakup (Percentage of Total Equity)

(AS ON 30.09.2010)

 

Category

 

Percentage

 

 

 

Foreign holdings [Foreign institutional investors, Foreign Companies, Foreign Financial Institutions, Non-resident Indian or Overseas corporate bodies or others]

 

17.00

Directors or relatives of directors

 

83.00

Total

 

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer and Trader of Pharmaceuticals and Bulk Drugs.

 

 

Products :

  • Pharmaceuticals
  • Bulk Drugs
  • Ethambutol (Combutol)
  • Insulin Injections
  • Pirazinamide Tablets
  • Prednisolone Sodium Injection
  • Diclofenace Sodium Injection

 

 

Terms :

 

Selling :

Cash and Credit [30-60 Days]

 

 

Purchasing :

Cash and Credit [30-60 Days]

 

 

PRODUCTION STATUS    (AS ON 31.03.2008)

 

Particulars

Unit

Installed Capacity

Actual Production

 

 

 

 

Liquid Injectable **

Kilo Litres

145.20

80.60

Dry Powder Injectables **

Tonnes

0.01

2.63

Liquid Orals * *

Kilo Litres

--

600.02

Tablets/Capsules **

Nos/Lakhs

16860.00

5536.39

Powders/Granules **

Tonnes

--

91.12

Ointments **

Tonnes

--

21.94

Spray / Bandage **

Tonnes

--

4.91

Bulk Drugs

Tonnes

15.00

4.29

Insulin

Kilo Ltrs

43.20

1.31

           

** Production includes loan licensee (third party) processing:

 

- Liquid injectables: 113.06 kilo litres, Dry powder injectables 0.77 tonnes

- Liquid oral: 600.02 kilo litres

- Tablet / Capsules: 1.564.84 numbers / lakhs

- Powder granules: 91.2 1 tonnes

- Ointment: 21.94 tonnes

- Spiny bandage: 4.91 tonnes

 

 

GENERAL INFORMATION

 

Customers :

  • End Users
  • OEM’s

 

 

No. of Employees :

Approximately 600

 

 

Bankers :

  • Indusind Bank, Ground Floor, Maker Chamber IV, Nariman Point, Mumbai -  400021, Maharashtra, India

 

  • Export Import Bank of India, Centre One Building Floor 21 : World Trade Centre, Cuffe Parade, Mumbai – 400005, Maharashtra, India

 

  • IDBI Bank

 

  • Axis Bank Limited, STR P M Road Branch, Fort, Mumbai – 400001, Maharashtra

 

  • Indian Overseas Bank, Andheri (West) Branch, Mumbai – 400058, Maharashtra, India

 

  • Bank of India, Mumbai Main Branch, M G Road, Fort Mumbai – 400001, Maharashtra, India
  • Bank of India, Mumbai MID Corporate Branch, 70/80, M.G. Road, Mumbai-400023, Maharashtra, India

 

  • State Bank of India, Industrial Finance Branch, Andheri [East], Mumbai – 400069

 

 

Facilities :

Secured Loan

31.03.2008

Rs. In Millions

31.03.2007

Rs. In Millions

Loans from Banks

 

 

- Term Loans

804.182

1011.237

- Export packing credit

134.955

38.139

- Cash Credit and working capital loans

725.030

528.553

- Vehicle Loans

1.012

1.484

Finance lease obligations

 

 

- Computers and software

24.517

0.000

- Vehicles

8.840

6.876

Total

1698.536

1586.289

 

 

 

Unsecured Loans

31.03.2008

Rs. In Millions

31.03.2007

Rs. In Millions

Short Term  Loan from Banks

100.000

0.000

Loan from Director

(Repayable on demand, Maximum amount outstanding during the year Rs. 80.787 Millions (Previous year Rs. 148.970 Millions)

2.033

80.787

Total

102.033

80.787

 

 

 

Banking Relations :

--

 

 

Financial Institute :

Indiabulls Financial Services Limited, F-60, Malhotra Building, 2nd Floor, Cannaught Palace, New Delhi – 110001, India

 

 

Auditors :

 

Name :

R G Mehta and Company

Chartered Accountants

Address :

B 203 Suchita Enclave Above ICICI Prudencial, Maharashtra Nagar, Borivali East, Mumbai – 400092, Maharashtra, India

 

 

Associates:

  • ZAO Shreya Corporation, Russia

Activities : Trading and Distribution of Pharma Products

 

  • Caps Rallis Private Limited
  • Shreya Biotech Private Limited
  • Shregran Hotels Private Limited
  • Shreya Creations Private Limited (U92100MH2000PTC124644)
  • Shreya Com Private Limited (U72900MH2000PTC126235)

 

 

Subsidiaries :

  • Serena Pharma Private Limited

CIN: U24239MH2001PTC131489

 

 

CAPITAL STRUCTURE

 

AS ON 30.09.2009

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

10000000

Equity Shares

Rs.10/- each

Rs.100.000 Millions

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

6295460

Equity Shares

Rs.10/- each

Rs.62.955 Millions

 

 

 

 

 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2009

31.03.2008

31.03.2007

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

62.955

62.955

62.955

2] Share Application Money

200.000

200.000

200.000

3] Reserves & Surplus

1622.101

1415.955

1162.370

4] (Accumulated Losses)

0.000

0.000

0.000

NETWORTH

1885.056

1678.910

1425.325

LOAN FUNDS

 

 

 

1] Secured Loans

1705.782

1698.536

1586.289

2] Unsecured Loans

95.148

102.033

80.787

TOTAL BORROWING

1800.930

1800.569

1667.076

DEFERRED TAX LIABILITIES

0.000

0.000

0.000

 

 

 

 

TOTAL

3685.986

3479.479

3092.401

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

1247.598

514.968

701.364

Capital work-in-progress

36.158

983.765

596.350

 

 

 

 

INVESTMENT

25.641

25.616

35.013

DEFERREX TAX ASSETS

58.792

31.799

10.071

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

307.978

259.662

202.751

 

Sundry Debtors

2919.624

2399.594

1789.328

 

Cash & Bank Balances

47.442

66.219

337.177

 

Other Current Assets

0.000

0.000

0.000

 

Loans & Advances

375.703

299.501

203.586

Total Current Assets

3650.747

3024.976

2532.842

Less : CURRENT LIABILITIES & PROVISIONS

 

 

 

 

Sundry Creditors

1269.496

881.937

638.219

 

Current Liabilities

145.907

110.056

 

Provisions

63.454

73.801

34.964

Total Current Liabilities

1332.950

1101.645

783.239

Net Current Assets

2317.797

1923.331

1749.603

 

 

 

 

MISCELLANEOUS EXPENSES

0.000

0.000

0.000

 

 

 

 

TOTAL

3685.986

3479.479

3092.401

 


 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

 

31.03.2008

31.03.2007

 

SALES

 

 

 

 

 

Income

 

4392.459

3479.269

 

 

Other Income

 

44.871

21.487

 

 

TOTAL                                     (A)

 

4437.330

3500.756

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Material Cost

 

1931.590

1361.977

 

 

Personnel Cost

 

312.414

297.547

 

 

Operating Expenses

 

1401.330

1158.820

 

 

Prior Period Expenses

 

129.728

0.000

 

 

TOTAL                                     (B)

 

3775.062

2818.344

 

 

 

 

 

Less

PROFIT BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B)      (C)

 

662.268

682.412

 

 

 

 

 

Less

FINANCIAL EXPENSES                         (D)

 

162.615

159.332

 

 

 

 

 

 

PROFIT BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D)                                       (E)

 

499.653

523.080

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                     (F)

 

207.457

219.407

 

 

 

 

 

 

PROFIT BEFORE TAX (E-F)                               (G)

 

292.196

303.673

 

 

 

 

 

Less

TAX                                                                  (I)

 

36.495

(21.476)

 

 

 

 

 

 

PROFIT AFTER TAX (G-I)                                  (J)

 

255.701

325.149

 

 

 

 

 

Add

PREVIOUS YEARS’ BALANCE BROUGHT FORWARD

 

644.324

319.175

 

 

 

 

 

Less

APPROPRIATIONS

 

 

 

 

 

Transfer to General Reserve

 

0.000

0.000

 

 

Dividend

 

0.000

0.000

 

 

Tax on Dividend

 

0.000

0.000

 

BALANCE CARRIED TO THE B/S

 

900.025

644.324

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

 

Export on F.O.B. Basis

 

1881.595

1475.996

 

 

Reimbursement of expenses

 

17.485

12.567

 

TOTAL EARNINGS

 

1899.080

1488.563

 

 

 

 

 

 

IMPORTS

 

 

 

 

 

Raw Materials / components

 

114.823

91.448

 

 

Capital Goods

 

13.959

46.869

 

TOTAL IMPORTS

 

128.782

138.317

 

 

 

 

 

 

Earnings Per Share (Rs.)

 

40.62

51.65

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2009

31.03.2008

31.03.2007

PAT / Total Income

(%)

NA

5.76

9.29

 

 

 

 

 

Net Profit Margin

(PBT/Sales)

(%)

NA

6.65

8.73

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

NA

8.25

9.39

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

NA

0.17

0.21

 

 

 

 

 

Debt Equity Ratio

(Total Liability/Networth)

 

1.66

1.73

1.72

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

2.74

2.75

3.23

 

 

LOCAL AGENCY FURTHER INFORMATION

 

 

BACKGROUND :

 

The Company is a private limited company under the Companies Act, 1956. The Company is primarily engaged in business of manufacturer and trading in wide range of pharmaceutical products. The company has its registered office in Mumbai.

 

Bankers Charges Report as per Registry

 

Corporate identity number of the company

U51900MH1991PTC061136

Name of the company

SHREYA LIFE SCIENCES PRIVATE LIMIYED

Address of the registered office or of the principal place of  business in India of the company

Shreya House, 6th Floor, 301/Apereira Hill Road, Andheri (East), Mumbai – 400099, Maharashtra, India

data@shreya.co.in

This form is for

 Modification of charge

Charge identification number of the charge to be modified

 90154738

Type of charge

Immovable Property

Particular of charge holder

Bank of India, Mumbai MID Corporate Branch, 70/80, M.G. Road, Mumbai-400023, Maharashtra, India

Nature of instrument creating charge

Memorandum of Entry

Date of instrument Creating the charge

27.10.2010

Amount secured by the charge

Rs. 1625.000 Millions

Brief of the principal terms an conditions and extent and operation of the charge

Rate of Interest

Interest shall be charged on the outstanding in the said account(s) at such rate or rates as may be determined by the said banks from time to time.

 

Terms of Repayment

On Demand

 

Margin

As may be stipulated by the bank form time to time

 

Extent and Operation of the charge

The company accorded and gave oral consent to Bank of India to continue to hold and retain the title deeds (by way of constructive delivery) in respect of its immovable properties as mentioned under Item No. 15 as security for repayment of Rs. 1625.000 Millions, together with interest, liquidated damages, costs, charges and expenses and all other money whatsoever due and payable by the company to the member banks.

 

Others

The charge created herein shall rank first pari passu inter se the members of Bank of India consortium and second charge for securing term loan of Rs. 400.000 Millions of SBI.

Short particulars of the property charged

Flat nos. 401 ands 402, 4th Floor, Shreya House, Pereira Hill Road, Andheri Kurla Road, Andheri (East), Mumbai-400099, Survey No. 301 and 301 to 13 of Village Gundivli, Andheri.

Particulars of the present modification

The mortgage / charge now stands secured upto Rs. 1625.000 Millions (comprising Bank of India Rs. 275.000 Millions, State Bank of India Rs. 350.000 Millions, India overseas Bank Rs. 250.000 Millions, Central Bank of India Rs. 350.000 Millions and State Bank of India its Term Loan of Rs. 400.000 Millions

 

 

Corporate identity number (CIN) Foreign company registration number

U51900MH1991PTC061136

Name of the Company

SHREYA LIFE SCIENCES PRIVATE LIMIYED

Address

Shreya House, 6th Floor, 301/Apereira Hill Road, Andheri (East), Mumbai – 400099, Maharashtra, India

data@shreya.co.in

This form is for

Creation of Charge

Type of Charge

·         Movable Property (not being pledge)

Particulars of the charge holder 

Indusind Bank Limited

Ground Floor, Maker Chambers Iv, Nariman Point, Mumbai – 400021, Maharashtra, India

vlaxman@vsnl.com

Nature or description of the instrument(s) creating or modifying the charge

Hypothecation agreement for Export Packing Credit.

Date of the instrument creating or modifying the charge

31.03.2007

Amount secured by the charge

Rs.97.500 Millions

Brief particulars of the principal terms and conditions and extent and operation of the charge

Rate of Interests:

Interest @ 18.75%p.a as applicable to inland advances at prevailing rates including interest tax for the entire period.

 

Term of Repayment:

On Demand

 

Margin:

As may be stipulated by the Bank from time to time.

 

Extent and operation of the charge:

Hypothecation of goods, as described under Item No.15 as security for repayment of credit facilities of Rs.97.500 Millions, together with all interest, costs, charges, expenses & other monies due and payable under the said facilities granted by the Bank to the Borrower.

Short particulars of the property charged (including location of the property)

All the goods and commodities viz. Stocks of materials procured under EPC now lying or thereafter stored at the godowns and yards and premises in Mumbai

 

 

Name of the company

SHREYA LIFE SCIENCES PRIVATE LIMIYED

Presented By

Axis Bank Limited

STR P M Road Branch, Fort, Mumbai – 400001

1) Date and description of instrument creating the change

Deed of Hypothecation of Machinery and other movable fixed assets no instrument. Memorandum of Entry (MOE), Equitable Mortgage by Deposit of Title Deeds.

 

Both Dated 07.01.2006 creating a single charge.

2) Amount secured by the charge/amount owing on the securities of charge

Working capital terms loan Rs.100.000 Millions

3) Short particular of the property charged. If the property acquired is subject to charge, date of the acquired of the property should be given

Hypothecation of all movable plant and machinery, furniture, fixture etc. both present and future being movable properties brought into stored at or at present installed at B/9-2, MIDC, Waluj Industries Area, Aurangabad – 431136 and the unit at plot No.13/14/15 Village Raipur, P O Bhagwanpur, District Haridwar, Roorkee, Uttaranchal – 247667 and the Plant and Machinery belonging to company or at its disposal or stored or be stored or brought into or upon or in course of transit, more particular described in schedule to deed of hypothecation.

 

Equitable Mortgage by deposit of title deeds, more particularly described in Annexure to first schedule to the MOE, in respect of immovable property being office premises No.801 on the 8th Floor, admeasuring 2000 sq. ft. super built up area including 8th Floor, Terrance pf the building known as Shreya House, Situate Lying and being at 1-A, 1-B and 1-C Pereira Hill Road, of village Gundavali, Taluka Andheri (East), Mumbai – 400099 more particularly described in Annexure to second schedule to the MOE together with the building and structure constructed/ to be constructed thereon.

4) Gist of the terms and conditions and extent and operation of the charge.

Interests, Repayment and other terms and conditions as specified by Bank from time to time.

5) Name and Address and description of the person entitled to the charge.

Axis Bank Limited

Fort Branch, Sir P M Road, Fort, Mumbai – 400001, India

 

 

Fixed Assets:

 

·         Leasehold Land

·         Freehold Land

·         Building

·         Plant and Machinery

·         Office Equipments, Furniture and Fittings

·         Computers Software

·         Vehicles

 

AS PER WEBSITE

 

Group Profile:

 

Shreya Group origins go back to Moscow, Russia, where Shreya Corporation, the parent company, was established in 1995. Once a one-man trading company, Subject is today the third largest Marketing and Distribution Company in Russia.

 

Shreya Group has interests in both pharmaceutical and biopharmaceutical products in key therapeutic segments. Currently, subject operates in Russia, CIS, India, South East Asia and African countries. The Group turnover for the year 2006 was US $ 581 million including US $ 85 million in India.

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                              None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.45.16

UK Pound

1

Rs.70.64

Euro

1

Rs.58.68

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

5

PAID-UP CAPITAL

1~10

5

OPERATING SCALE

1~10

5

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

6

--PROFITABILIRY

1~10

6

--LIQUIDITY

1~10

6

--LEVERAGE

1~10

5

--RESERVES

1~10

6

--CREDIT LINES

1~10

6

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

YES

--AFFILIATION

YES/NO

NO

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

TOTAL

 

50

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

-

NB

                                       New Business

-

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.